Eton Pharmaceuticals Inc., of Deer Park, Ill., said it priced its IPO of 3.6 million shares at $6 each. The underwriter in the offering has been granted a 45-day option to purchase an additional 540,000 shares at the IPO price, less underwriting discounts and commissions.